Moreover, skeletal muscle, as the primary site of insulin-stimulated glucose uptake, has been implicated as a major driver of systemic insulin resistance; patients with skeletal muscle atrophy often develop insulin resistance, resulting in lower glucose utilization, which in turn stimulates fat synthesis and storage (37). This evidence concerns the gene INS and Skeletal muscle atrophy.